Category: Mcd_RX-3Things

• ‌‌Majority of GLP-1 Prescriptions Paid by Commercial Insurance.
• Modest reaction to $7.5B Medicare drug price cuts
• CMS Unveils Final coverage Pathway guidance for breakthrough devices, but Industry Pushes for Legislative Fix.

• ‌‌CMS releases new Part D information for 2025 bids.
• Medicaid coverage as factor to increase clinical trial participant racial diversity
• FDA Digital Health advisory committee updates‌

• ‌‌Retro study looks at Hep-C market access approaches for Medicaid during initial rollout.
• CMS releases new guidance on Medicare drug program member outreach and co-pay rules.
• Pharmacies sue UnitedHealthcare over security failures.‌

Check out the audio version above, or on Spotify

• ‌‌PBM lawsuits in the works
• NC to cover weight loss drugs
• Bluebird fertility gene therapy dealt blow in bid for Medicaid coverage

Check out the audio version above, or on Spotify

• ‌Conduent keeps Montana PBM business
• Industry struggles to fight Medicare price negations under IRA
• CT adds rapid genetic testing to Medicaid benefit

Check out the audio version above, or on Spotify

• CMS Cell and Gene Therapy (CGT) Access Model 
• OptumRx to pay $20M to settle opioid trafficking claims
• Congress moves to expedite device coverage while waiting on CMS national coverage determination process.

Check out the audio version above, or on Spotify

• New CBO report on Medicaid Hep C treatment impact 
• Amazon expands RxPass to Medicare members 
• Missouri moves to prevent limits on contract pharmacies for 340B

Check out the audio version above, or on Spotify

• FDA launches Payor Communication Task Force
• Public comment period for data collection under Medicare Drug Inflation Rebate Program
• CT expands bio marker testing for Medicaid members.

Check out the audio version above, or on Spotify

• ‌‌‌Manufacturers signal impact of Inflation Reduction Act on innovation
• 340B issues in the news
• CO Governor relaxes prior auth for MH/BH drugs

Check out the audio version above, or on Spotify

• ‌NY 340B expansion talks continue
• 157 state bills in play to regulate PBMs
• AstraZeneca loses in Delaware over its challenge to the Inflation Reduction Act

Check out the audio version above, or on Spotify